LTRN
Lantern Pharma Inc. Common Stock
$3.230+-0.000 (-0.000%)
실시간 가격
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$3.230
고가
$3.230
저가
$3.230
거래량
0.11M
기업 기본 정보
거래 통계
관련 뉴스
BusinessWire
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates
Completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors expected by end of June 2025. Additional patient data readout from the HARMONIC™ Trial evaluating
더 보기
BusinessWire
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
The FDA has cleared the investigational new drug (IND) application of LP-184 in triple negative breast cancer (TNBC) treatment – a novel small molecule advanced and developed with Lantern's AI platform,
더 보기
